We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+15.81%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$603M
AUM Growth
-$8.68M
(-1.4%)
Cap. Flow
-$46.2M
Cap. Flow
% of AUM
-7.66%
Top 10 Holdings %
Top 10 Hldgs %
7.77%
Holding
1,678
New
527
Increased
200
Reduced
321
Closed
629
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$7.12M |
| 2 |
Gaotu Techedu
GOTU
|
+$6.67M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$5.77M |
| 4 |
Vipshop
VIPS
|
+$5.57M |
| 5 |
Tencent Music
TME
|
+$5.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$3.36M |
| 2 |
VRNT
Verint Systems
VRNT
|
+$3.09M |
| 3 |
Medifast
MED
|
+$2.5M |
| 4 |
LOVE
LoveSac
LOVE
|
+$2.41M |
| 5 |
KKR & Co
KKR
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 24.29% |
| 2 | Healthcare | 13.21% |
| 3 | Industrials | 11.54% |
| 4 | Technology | 11.13% |
| 5 | Financials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Atara Biotherapeutics
ATRA
$76.1M
| $187K | 0.03% |
+520
| New | +$230K |
|
927
Adtran
ADTN
$616M
| $186K | 0.03% |
11,122
-20,384
| -65% | -$343K |
|
|
NAGE
928
Niagen Bioscience
NAGE
$247M
| $186K | 0.03% |
19,886
-39,335
| -66% | -$312K |
|
|
SOS
929
SOS Limited
SOS
$14.6M
| $184K | 0.03% |
+49
| New | +$192K |
|
930
Acacia Research
ACTG
$470M
| $183K | 0.03% |
+27,492
| New | +$173K |
|
931
Clarus
CLAR
$143M
| $183K | 0.03% |
+10,739
| New | +$183K |
|
932
Acco Brands
ACCO
$407M
| $181K | 0.03% |
+21,491
| New | +$185K |
|
933
DHT Holdings
DHT
$3.02B
| $180K | 0.03% |
+30,344
| New | +$176K |
|
934
Enviri
NVRI
$620M
| $175K | 0.03% |
+10,193
| New | +$185K |
|
|
DCH
935
Dauch Corp
DCH
$1.51B
| $174K | 0.03% |
18,031
-34,441
| -66% | -$341K |
|
936
ProQR Therapeutics
PRQR
$265M
| $173K | 0.03% |
26,152
-21,473
| -45% | -$110K |
|
937
Kopin
KOPN
$791M
| $171K | 0.03% |
16,328
-200,517
| -92% | -$1.52M |
|
938
Golub Capital BDC
GBDC
$3.42B
| $170K | 0.03% |
+11,619
| New | +$171K |
|
|
AIM
939
AIM ImmunoTech
AIM
$7.91M
| $170K | 0.03% |
749
+578
| +338% | +$131K |
|
940
Oceaneering
OII
$4.77B
| $169K | 0.03% |
14,830
-98,163
| -87% | -$1.09M |
|
941
Macerich
MAC
$6.92B
| $168K | 0.03% |
14,364
-46,867
| -77% | -$627K |
|
942
Amneal Pharmaceuticals
AMRX
$5.79B
| $167K | 0.03% |
24,867
-14,685
| -37% | -$81.4K |
|
943
Mitsubishi UFJ Financial
MUFG
$254B
| $166K | 0.03% |
30,917
+19,738
| +177% | +$102K |
|
944
Fossil Group
FOSL
$318M
| $165K | 0.03% |
+13,302
| New | +$186K |
|
945
Teekay Tankers
TNK
$2.68B
| $164K | 0.03% |
+11,795
| New | +$150K |
|
|
XRN
946
Chiron Real Estate Inc
XRN
$477M
| $163K | 0.03% |
2,494
-1,211
| -33% | -$80.5K |
|
|
VLDR
947
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $163K | 0.03% |
+14,334
| New | +$270K |
|
|
NNA
948
DELISTED
Navios Maritime Acquisition Corporation
NNA
| $160K | 0.03% |
+39,387
| New | +$150K |
|
949
Rayonier Advanced Materials
RYAM
$610M
| $158K | 0.03% |
+17,402
| New | +$150K |
|
950
KALA BIO
KALA
$14.5M
| $156K | 0.03% |
9
+5
| +125% | +$97.6K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, GSA Capital Partners held 1,678 positions worth $603M, down 1.4% from $611M the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
GSA Capital Partners withdrew a net $46.2M in Q1 2021, closing 629 positions and reducing 321 holdings. Its most notable exit was Just Eat Takeaway.com N.V. American Depositary Shares, an estimated $3.36M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, GSA Capital Partners opened a new position in Baidu worth $5.94M.
- GSA Capital Partners's largest Q1 2021 buy was Baidu: 27,291 shares worth $5.94M.
- GSA Capital Partners added most to Tencent Music in Q1 2021, an estimated $5.35M increase.
- GSA Capital Partners's biggest Q1 2021 reduction was Medifast, cutting an estimated $2.5M.
- GSA Capital Partners fully exited Just Eat Takeaway.com N.V. American Depositary Shares in Q1 2021, selling an estimated $3.36M.
- GSA Capital Partners's ten largest holdings make up 7.8% of its $603M portfolio in Q1 2021.
- GSA Capital Partners opened 527 new positions and closed 629 in Q1 2021.
- GSA Capital Partners's portfolio value fell 1.4% quarter-over-quarter to $603M.
Based on GSA Capital Partners's 13F filing for Q1 2021, filed 10 May 2021.